|
Maximum Tolerated Dose Clinical Trials
2 actively recruiting trials across 1 location
▲ +1 trial since August 2026
Pipeline
Phase 1: 2
Top Sponsors
- Medical College of Wisconsin1
- Institute of Cancer Research, United Kingdom1
Indications
- Cancer2
- High-grade Serous Ovarian Cancer1
- Multiple Myeloma1
Other1 trial
Milwaukee, Wisconsin1 trial
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
Froedtert & the Medical College of Wisconsin
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.